Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Dosage Regimen: Overview01:15

Drug Dosage Regimen: Overview

4.1K
A drug dosage regimen describes the specific instructions and schedule for administering a drug to a patient. It considers factors such as drug dosage, frequency, route of administration, and duration of treatment. Designing an appropriate dosage regimen for a patient aims to achieve a target drug concentration at the site of action.
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
4.1K
Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

400
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
400
Dosage Regimens: Designs and Approaches01:28

Dosage Regimens: Designs and Approaches

605
Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...
605
Pharmacovigilance01:19

Pharmacovigilance

2.0K
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
2.0K
Drug Administration and Therapy Phases: Overview01:26

Drug Administration and Therapy Phases: Overview

2.0K
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
2.0K
Dosage Interval and Administration Route: Determination Methods01:19

Dosage Interval and Administration Route: Determination Methods

572
A medication’s effectiveness largely depends on its appropriate dosage and the route of administration. Dosage ensures that a sufficient drug concentration is maintained in the bloodstream to elicit the desired therapeutic effect without causing toxicity. The route of administration affects the drug's bioavailability, rate of absorption, and onset of action, which are crucial for achieving optimal therapeutic outcomes. Drug dosage calculations are critical to tailoring therapy to...
572

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Multilevel Stewardship Intervention for Use of Anticoagulation-Antiplatelet Therapy.

JAMA internal medicine·2026
Same author

Real-Time Benefit Tools in 2026-More Work Is Needed.

JAMA network open·2026
Same author

Antihypertensive Medication Use and Prescription Discontinuation Among Postpartum Women.

American journal of hypertension·2026
Same author

Trajectories of Treatment Disruption for Chronic Outpatient Medications for U.S. Veterans During Drug Shortages.

Pharmacoepidemiology and drug safety·2026
Same author

Age-Related Patterns and Longitudinal Trends in Psychotropic Medication Use Among Commercially Insured Children with Autism Spectrum Disorder in the United States: A Claims Database Study.

Journal of child and adolescent psychopharmacology·2026
Same author

Development of a decision aid to help dually enrolled veterans make informed choices on medication sourcing.

Journal of managed care & specialty pharmacy·2026
Same journal

Zoliflodacin: A novel single-dose oral antibiotic for uncomplicated urogenital gonorrhea.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists·2026
Same journal

Implementation of a paid apprenticeship-model pharmacy technician training program.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists·2026
Same journal

Iodixanol-induced acute generalized exanthematous pustulosis: Cross-reactivity to other iodinated contrast media.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists·2026
Same journal

Sonrotoclax.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists·2026
Same journal

Bulevirtide Acetate-gmod.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists·2026
Same journal

Addressing feedback overload in pharmacy residents.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists·2026
See all related articles

Related Experiment Video

Updated: May 5, 2026

Iterative Development of an Innovative Smartphone-Based Dietary Assessment Tool: Traqq
04:54

Iterative Development of an Innovative Smartphone-Based Dietary Assessment Tool: Traqq

Published on: March 19, 2021

4.9K

Medication-use evaluation with a Web application.

Muriel Burk1, Von Moore, Peter Glassman

  • 1Muriel Burk, Pharm.D., is Clinical Pharmacy Specialist, Veterans Affairs (VA) Center for Medication Safety, Hines, IL. Von Moore, Pharm.D., is Research Specialist, VA Center for Medication Safety, VA Northern Indiana Health Care System, Marion. Peter Glassman, M.B.B.S., M.Sc., FACP, is Co-Director, VA Center for Medication Safety, Division of General Internal Medicine, VA Greater Los Angeles Healthcare System, West Los Angeles, CA. Chester B. Good, M.D., M.P.H., is Co-Director, VA Center for Medication Safety, Division of General Internal Medicine, VA Pittsburgh Healthcare System, Pittsburgh, PA. Thomas Emmendorfer, Pharm.D., is Assistant Chief Consultant, VA Pharmacy Benefits Management Services, Hines, IL. Thomas C. Leadholm, M.S., is Information Technology Specialist, VA Consolidated Mail Outpatient Pharmacy/VA Center for Medication Safety, Dexter, MI. Francesca Cunningham, Pharm.D., is Director, VA Center for Medication Safety, Hines.

American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
|December 4, 2013
PubMed
Summary
This summary is machine-generated.

The Medication-Use Evaluation Tracker (MUET) improves medication safety across Veterans Affairs (VA) by coordinating interventions and monitoring prescribing. This pharmacovigilance tool enhances patient care and supports quality improvement initiatives.

More Related Videos

The Dyspepsia Educational Tool As a Novel Aid in Dyspepsia Management
06:40

The Dyspepsia Educational Tool As a Novel Aid in Dyspepsia Management

Published on: June 29, 2019

6.3K
'Boden Food Plate': Novel Interactive Web-based Method for the Assessment of Dietary Intake
04:46

'Boden Food Plate': Novel Interactive Web-based Method for the Assessment of Dietary Intake

Published on: September 18, 2018

6.8K

Related Experiment Videos

Last Updated: May 5, 2026

Iterative Development of an Innovative Smartphone-Based Dietary Assessment Tool: Traqq
04:54

Iterative Development of an Innovative Smartphone-Based Dietary Assessment Tool: Traqq

Published on: March 19, 2021

4.9K
The Dyspepsia Educational Tool As a Novel Aid in Dyspepsia Management
06:40

The Dyspepsia Educational Tool As a Novel Aid in Dyspepsia Management

Published on: June 29, 2019

6.3K
'Boden Food Plate': Novel Interactive Web-based Method for the Assessment of Dietary Intake
04:46

'Boden Food Plate': Novel Interactive Web-based Method for the Assessment of Dietary Intake

Published on: September 18, 2018

6.8K

Area of Science:

  • Health Informatics
  • Pharmacovigilance
  • Health Services Research

Background:

  • Medication safety is a critical component of healthcare quality.
  • Large integrated health systems require robust tools for monitoring medication use.
  • The Veterans Affairs (VA) health care system sought to enhance its medication-use evaluation (MUE) capabilities.

Purpose of the Study:

  • To describe a Web-based application, the MUE Tracker (MUET), designed for coordinating MUE initiatives within the VA.
  • To improve the VA's capacity for conducting national, medication-related interventions.
  • To centralize the coordination and tracking of medication safety efforts.

Main Methods:

  • Development of the MUET software, a secure Web-based application.
  • Centralized coordination by the VA Center for Medication Safety (VAMedSAFE).
  • Utilizing integrated databases to detect pharmacovigilance signals and identify at-risk patient groups.
  • Local personnel (pharmacists) access patient lists for targeted interventions.
  • Centralized storage and updating of patient-specific intervention data for tracking and reporting.

Main Results:

  • A three-year pilot project demonstrated MUET's effectiveness in improving prescribing and monitoring of erythropoiesis-stimulating agents (ESAs).
  • The program successfully targeted risk-reduction efforts in specified patient groups.
  • MUET facilitated improved laboratory monitoring for patients receiving ESAs.
  • The initiative has been expanded to include other high-risk medications.

Conclusions:

  • The MUET application has standardized medication safety initiatives across the VA.
  • It enables effective tracking, reporting, and analysis for quality improvement and provider education.
  • MUET serves as a valuable model for other large health care systems developing pharmacovigilance tools.